Compounds > finasteride

finasteride and Carcinoma, Transitional Cell

finasteride has been researched along with Carcinoma, Transitional Cell in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Fradet, V; Fradet, Y; Lacombe, L; Lodde, M; McMartin, C; Toren, P1
Juan, YS; Lee, HY; Li, CC; Wang, CS; Wu, WJ1
Barber, NJ; Donohue, JF1

Other Studies

3 other study(ies) available for finasteride and Carcinoma, Transitional Cell

ArticleYear
Receipt of 5-Alpha Reductase Inhibitors Before Radical Cystectomy: Do They Render High-Grade Bladder Tumors Less Aggressive?
    Clinical genitourinary cancer, 2019, Volume: 17, Issue:6

    Topics: 5-alpha Reductase Inhibitors; Aged; Carcinoma, Transitional Cell; Cystectomy; Dutasteride; Finasteride; Humans; Logistic Models; Male; Margins of Excision; Neoadjuvant Therapy; Neoplasm Invasiveness; Retrospective Studies; Survival Analysis; Treatment Outcome; Urinary Bladder Neoplasms

2019
5α-reductase inhibitors impact prognosis of urothelial carcinoma.
    BMC cancer, 2020, Sep-11, Volume: 20, Issue:1

    Topics: 5-alpha Reductase Inhibitors; Aged; Carcinoma; Carcinoma, Transitional Cell; Cholestenone 5 alpha-Reductase; Dutasteride; Finasteride; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Prostatic Hyperplasia; Receptors, Androgen; Taiwan; Urothelium

2020
How do we investigate haematuria and what role has finasteride?
    BJU international, 2004, Volume: 93, Issue:1

    Topics: Carcinoma, Transitional Cell; Enzyme Inhibitors; Finasteride; Health Care Surveys; Hematuria; Humans; Professional Practice; Referral and Consultation; Urinary Bladder Neoplasms

2004